Search results
CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab,...
The Pendulum· 4 days agoSugemalimab is expected to become the first anti-PD-L1 monoclonal antibody (mAb) in the world approved in Europe for both first-line squamous and non-squamous NSCLC, regardless of PD-L1 expression ...
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival
Reuters· 5 days ago, opens new tab Trodelvy failed to improve survival for patients with advanced bladder cancer and...
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 3 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
Summit Shares Soar After Lung Cancer Drug Tops Keytruda in Study
Bloomberg· 6 days agoSummit Therapeutics Inc. shares jumped after the biotech company said a late-stage trial met its...
Phase III trial shows lorlatinib highly effective against ALK-positive non–small cell lung cancer
Medical Xpress· 1 day agoA large team of medical researchers and doctors has found via phase III clinical trial that the ALK inhibitor lorlatinib is highly effective for treating non–small cell lung
Ronnie Wood admits 'I shouldn't be here' after double cancer diagnosis
Daily Express· 4 days agoRonnie Wood believed he was handed a death sentence after being diagnosed with cancer. The Rolling...
Summit Therapeutics’ stock surges as lung-cancer treatment vies with Merck’s blockbuster
Market Watch· 6 days agoInc.’s blockbuster Keytruda in a late-stage clinical trial. The trial compared the Summit drug,...
South Coast Plaza installation offers 'Music of Hope' to honor cancer survivors
Los Angeles Times· 20 hours agoMichelle Vacca remembers calling into KROQ radio station during the 1980s and winning Beastie Boys...
Virtual and In-Person Palliative Care Equally Beneficial in Advanced Lung Cancer
MedPage Today· 4 days agoEarly palliative care delivered via video was as effective as in-person visits on quality-of-life...
New Pathways for Treating Never-Smoker Lung Cancer | Newswise
Newswise· 3 days agoKorean joint research team have elucidated the overexpression of estrogen signaling pathways in specific Korean never-smoking lung cancer cases using multi